Predominance of clarithromycin-susceptible Mycobacterium massiliense subspecies: Characterization of the Mycobacterium abscessus complex at a tertiary acute care hospital
To characterize members of the Mycobacterium abscessus complex, with an emphasis on the correlation between species identification and clarithromycin associated genetic polymorphisms that contribute to inducible and constitutive macrolide resistance. PCR and sequencing analysis was used to elucidate the subspecies, erm(41) genotypes and the presence of rrl mutations. M. abscessus subsp. massiliense was the dominant subspecies (70.2 %), followed by M. abscessus subsp. abscessus (23.8 %) and M. abscessus subsp. bolletii (5.9 %). The majority of M. abscessus and M. bolletii isolates possessed T28 erm(41) sequevar and were inducibly resistant to clarithromycin. All M. massiliense carried the truncated erm(41) and were largely clarithromycin-susceptible (98.3 %). Constitutive resistance involving rrl mutations was rare and seen in only 2 isolates (2.2 %). Subspecies identification was insufficient to predict clarithromycin susceptibility and required the genetic resistance to be determined via sequencing. In our context, rrl mutations were uncommon and may not be an essential test.
GriffithDE, AksamitT, Brown-ElliottBA, CatanzaroA, DaleyC et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med2007; 175:367–416 [View Article][PubMed]
AitkenML, LimayeA, PottingerP, WhimbeyE, GossCH et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med2012; 185:231–232
KimYS, YangCS, NguyenLT, KimJK, JinHS et al.Mycobacterium abscessus ESX-3 plays an important role in host inflammatory and pathological responses during infection. Microbes Infect2017; 19:5–17 [View Article][PubMed]
KohWJ, JeonK, LeeNY, KimBJ, KookYH et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med2011; 183:405–410 [View Article][PubMed]
WoodsGL, Brown-ElliottBA, ConvillePS, DesmondEP, HallGS et al.Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes, 2nd ed. Approval Standard M24-A2 Wayne, PA: Clinical and Laboratory Standards Institute; 2011
NashKA, Brown-ElliottBA, WallaceRJ. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother2009; 53:1367–1376 [View Article][PubMed]
BastianS, VezirisN, RouxAL, BrossierF, GaillardJL et al. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother2011; 55:775–781 [View Article][PubMed]
WallaceRJ, MeierA, BrownBA, ZhangY, SanderP et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother1996; 40:1676–1681[PubMed]
KimH, KimSH, ShimTS, KimMN, BaiGH et al. Differentiation of Mycobacterium species by analysis of the heat-shock protein 65 gene (hsp65). Int J Syst Evol Microbiol2005; 55:1649–1656 [View Article][PubMed]
Brown-ElliottBA, VasireddyS, VasireddyR, IakhiaevaE, HowardST et al. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs. J Clin Microbiol2015; 53:1211–1215 [View Article][PubMed]
ChuaKY, BustamanteA, JelfsP, ChenSC, SintchenkoV. Antibiotic susceptibility of diverse Mycobacterium abscessus complex strains in New South Wales, Australia. Pathology2015; 47:678–682 [View Article][PubMed]
NieW, DuanH, HuangH, LuY, BiD et al. Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics. Int J Infect Dis2014; 25:170–174 [View Article][PubMed]
KimHY, KookY, YunYJ, ParkCG, LeeNY et al. Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. J Clin Microbiol2008; 46:3384–3390 [View Article][PubMed]
ShallomSJ, GardinaPJ, MyersTG, SebastianY, ConvilleP et al. New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance. J Clin Microbiol2013; 51:2943–2949 [View Article][PubMed]
MaurerFP, RüeggerV, RitterC, BloembergGV, BöttgerEC. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41). J Antimicrob Chemother2012; 67:2606–2611 [View Article][PubMed]
MougariF, LoiseauJ, VezirisN, BernardC, BercotB et al. Evaluation of the new genotype NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria. J Antimicrob Chemother2017; 72:1669–1677 [View Article][PubMed]
Predominance of clarithromycin-susceptible Mycobacterium massiliense subspecies: Characterization of the Mycobacterium abscessus complex at a tertiary acute care hospital